Home
/
Treatment
/
2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt

2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt

	2-(2-phenylvinyl)-4-[-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt
Trade Name
Orphan Indication	Acute myeloid leukemia
USA Market Approval	USA
USA Designation Date	2010-01-29 00:00:00
Sponsor	EntreMed, Inc.;Research Triangle Park Center, Suite 400;Durham, North Carolina, 27703